Dose comparison of robustly optimized intensity modulated proton therapy (IMPT) vs IMRT and VMAT photon plans for testicular seminoma.

Heidi S RøndeCamilla KronborgMorten HøyerJolanta HansenMalene Eppler BakSøren Nielsen AgergaardAnne Birgitte AlsMads AgerbækJakob LauritsenPeter Meidahl PetersenLars DysagerJesper Folsted Kallehauge

Published in: Acta oncologica (Stockholm, Sweden) (2023)

Proton therapy reduced radiation dose to OAR compared to both IMRT and VMAT plans, and potentially reduce the risk of secondary cancer both overall and for most OAR.

Keyphrases

germ cell
health insurance
papillary thyroid
squamous cell
living cells
squamous cell carcinoma
childhood cancer
clinical evaluation